A detailed history of Aptus Capital Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Aptus Capital Advisors, LLC holds 99,660 shares of PFE stock, worth $2.5 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
99,660
Previous 258,952 61.51%
Holding current value
$2.5 Million
Previous $7.25 Million 60.19%
% of portfolio
0.05%
Previous 0.14%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$27.7 - $31.39 $4.41 Million - $5 Million
-159,292 Reduced 61.51%
99,660 $2.88 Million
Q2 2024

Jul 31, 2024

BUY
$25.26 - $29.6 $933,584 - $1.09 Million
36,959 Added 16.65%
258,952 $7.25 Million
Q1 2024

May 15, 2024

BUY
$25.89 - $29.73 $1.04 Million - $1.19 Million
40,097 Added 22.04%
221,993 $6.16 Million
Q4 2023

Feb 13, 2024

SELL
$26.13 - $33.94 $1.04 Million - $1.35 Million
-39,784 Reduced 17.95%
181,896 $5.24 Million
Q3 2023

Nov 08, 2023

BUY
$32.09 - $37.51 $137,666 - $160,917
4,290 Added 1.97%
221,680 $7.35 Million
Q2 2023

Aug 11, 2023

BUY
$36.12 - $41.79 $340,719 - $394,205
9,433 Added 4.54%
217,390 $7.97 Million
Q1 2023

May 09, 2023

BUY
$39.39 - $51.28 $1.95 Million - $2.54 Million
49,569 Added 31.3%
207,957 $8.48 Million
Q4 2022

Feb 13, 2023

BUY
$41.75 - $54.5 $4.15 Million - $5.42 Million
99,487 Added 168.91%
158,388 $8.12 Million
Q3 2022

Nov 02, 2022

BUY
$43.76 - $53.42 $358,175 - $437,242
8,185 Added 16.14%
58,901 $2.58 Million
Q2 2022

Jul 29, 2022

BUY
$46.53 - $55.17 $1.56 Million - $1.85 Million
33,557 Added 195.57%
50,716 $2.66 Million
Q1 2022

May 04, 2022

BUY
$45.75 - $56.69 $464,042 - $575,006
10,143 Added 144.57%
17,159 $888,000
Q4 2021

Feb 02, 2022

BUY
$41.32 - $61.25 $4,379 - $6,492
106 Added 1.53%
7,016 $414,000
Q3 2021

Oct 27, 2021

SELL
$39.25 - $50.42 $25,002 - $32,117
-637 Reduced 8.44%
6,910 $297,000
Q2 2021

Jul 27, 2021

BUY
$35.91 - $40.68 $66,505 - $75,339
1,852 Added 32.52%
7,547 $296,000
Q1 2021

May 06, 2021

SELL
$33.49 - $37.77 $1.49 Million - $1.68 Million
-44,387 Reduced 88.63%
5,695 $206,000
Q4 2020

Feb 10, 2021

BUY
$33.47 - $42.56 $205,974 - $261,914
6,154 Added 14.01%
50,082 $1.84 Million
Q3 2020

Oct 19, 2020

SELL
$31.75 - $37.25 $824,960 - $967,866
-25,983 Reduced 37.17%
43,928 $1.61 Million
Q2 2020

Jul 22, 2020

BUY
$30.12 - $36.54 $37,951 - $46,040
1,260 Added 1.84%
69,911 $2.29 Million
Q1 2020

May 07, 2020

SELL
$27.03 - $38.62 $160,450 - $229,248
-5,936 Reduced 7.96%
68,651 $2.24 Million
Q4 2019

Feb 10, 2020

SELL
$32.92 - $37.36 $583,144 - $661,795
-17,714 Reduced 19.19%
74,587 $2.92 Million
Q3 2019

Nov 12, 2019

BUY
$32.49 - $42.13 $1.37 Million - $1.77 Million
42,023 Added 83.58%
92,301 $3.32 Million
Q2 2019

Aug 13, 2019

SELL
$36.98 - $41.52 $6,064 - $6,809
-164 Reduced 0.33%
50,278 $2.18 Million
Q1 2019

May 15, 2019

BUY
$37.5 - $41.2 $462,525 - $508,160
12,334 Added 32.37%
50,442 $2.14 Million
Q4 2018

Feb 12, 2019

BUY
$38.47 - $43.86 $1.47 Million - $1.67 Million
38,108 New
38,108 $1.66 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $141B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Aptus Capital Advisors, LLC Portfolio

Follow Aptus Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aptus Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aptus Capital Advisors, LLC with notifications on news.